NCARDIA

In News

iPSC technology company Ncardia receives US$60 million investment - RegMedNet

RegMedNet - Nov 17, 2021

Ncardia Launches Panel of Ready-to-Use Assays to Streamline Screening and Selection of New Therapeutic Candidates - BioInformant

BioInformant - Sep 10, 2024

Ncardia inks $60M funding deal to expand discovery and commercial production services for stem cells - Fierce Biotech

Fierce Biotech - Nov 16, 2021

An ethical shift in NHP research: iPSC-derived cardiomyocytes for safer pharmacology - Drug Target Review

Drug Target Review - Oct 06, 2025

New platform to accelerate cardiac drug development - Leids Universitair Medisch Centrum | LUMC

Leids Universitair Medisch Centrum | LUMC - Jan 22, 2026

Ncardia Expands iPSC Manufacturing and Phenotypic Drug Discovery Services With Support From Investors - PR Newswire

PR Newswire - Jul 15, 2019

Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings - Business Wire

Business Wire - Nov 16, 2021

Ncardia Launches Cellistic™, the Only iPSC-based Cell Therapy Process Development & Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - BioInformant

BioInformant - Apr 26, 2022

On back of Roche pact, newly formed Ncardia wins iPSC deal with Evotec - Fierce Biotech

Fierce Biotech - Dec 06, 2017

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction - Business Wire

Business Wire - Sep 20, 2022

Ncardia Launches Ncyte® Heart in a Box to Advance Cardiovascular Research and Precision Medicine - DutchNews.nl

DutchNews.nl - Jan 27, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment